FDA proposal would let toxic chemicals be added directly to food without safety review, advocates warn

Expansion of 'threshold of regulation' exemption sits inside rule closing the separate GRAS loophole

By LineZotpaper
Published
Read Time2 min
The US Food and Drug Administration is proposing to expand a controversial exemption so that some of the world's most toxic chemicals could be added directly to food as ingredients without a safety review, according to public health advocates alarmed by the plan.

The change would extend the FDA's "threshold of regulation" (TOR) exemption, which currently allows potentially dangerous compounds to be used without review in food contact materials such as packaging or processing equipment, provided they are not carcinogenic and are present at levels below 0.5 parts per billion (ppb).

Under the new proposal, chemicals could also be used as ingredients added directly to food: as flavourings, preservatives, emulsifiers, processing aids, enzymes, stabilizers and binders, and for other purposes in ultra-processing.

The proposal was disclosed as part of a rule the FDA submitted to the Federal Register, the same month Robert F Kennedy Jr and the agency declared "promises kept" for closing the separate "generally regarded as safe" (GRAS) loophole, which had long allowed ingredients onto the market without review. Advocates say the TOR expansion, which was not mentioned in the public relations material, could undermine that claimed victory, and some have accused Kennedy of deception.

Critics argue the 0.5 ppb threshold is flawed because some chemicals, particularly hormone disruptors linked to brain damage and reproductive harm in children, are dangerous at far lower levels. They point to an existing TOR exemption that allowed the rocket fuel chemical perchlorate to be used in grain bags, dramatically increasing the amount of the compound found in children's cereal.

"The FDA and industry have this position that if there's only a little bit of something in the diet, then it's not going to be problematic, but that isn't supported by science of any kind," said Maricel Maffini, an independent food consultant who has worked on TOR issues.

"I don't know how they're going to square that circle because there are many ingredients that at very low levels also cause serious issues in the body," she added.

The FDA did not respond to a request for comment. Advocates described the proposal as a major win for big food, based on flawed science.

§

Analysis

Why This Matters

  • The plan would extend a review-free pathway from food packaging to the food itself, covering flavourings, preservatives, processing aids and other additives.
  • Chemicals that are dangerous below the 0.5 ppb threshold, such as hormone disruptors, would escape pre-market scrutiny.
  • It comes as the FDA announced a public win on food safety, raising questions about whether that reform is as comprehensive as claimed.

Background

The TOR exemption has long allowed certain substances in food contact materials to skip FDA review on the theory that tiny amounts pose no risk. The perchlorate case shows the stakes: an exemption for the rocket fuel chemical in grain bags sharply increased levels found in children's cereal, and environmental advocates joined a court challenge over the FDA's refusal to ban the use. The new rule would apply the same logic to ingredients added directly to food, rather than only to packaging and equipment.

Key Perspectives

Public health advocates: Say the dose-based reasoning is unsupported by science, describe the proposal as a major win for big food, and accuse officials of failing to disclose the expansion when announcing the GRAS closure. The FDA and Robert F Kennedy Jr: Presented the August rulemaking as fulfilling promised food safety reforms. The agency has not responded to requests for comment on the TOR expansion. The food industry: Stands to gain faster, cheaper access to ingredients without pre-market safety reviews, which is why advocates characterise the move as a win for manufacturers.

What to Watch

  • The Federal Register rulemaking process: specifically whether the TOR expansion survives in the final rule.
  • The FDA's response to criticism of the 0.5 ppb threshold, which is central to the debate.
  • Potential legal challenges, following the precedent of the perchlorate court fight.

Sources

Zotpaper

Written by software from the reporting listed above, scored by an automated standards desk, and published without a person reading it first. If something here is wrong, tell the editor and it will be put right.

How we workSubscribe